Industry Insights: GLP-1s vs Insulin – A Game Changer for Diabetes and Cancer Risk
The diabetes industry is constantly evolving, with new research and treatments emerging regularly. A recent study published in JAMA Network Open has shed light on a significant development in the field. The study reveals that diabetes patients using GLP-1s instead of insulin have a lower risk of developing certain cancers. This article will delve into…